0001802806-22-000008.txt : 20220824
0001802806-22-000008.hdr.sgml : 20220824
20220824160329
ACCESSION NUMBER: 0001802806-22-000008
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220824
DATE AS OF CHANGE: 20220824
EFFECTIVENESS DATE: 20220824
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: GELESIS HOLDINGS, INC.
CENTRAL INDEX KEY: 0001805087
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 844730610
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-456915
FILM NUMBER: 221191547
BUSINESS ADDRESS:
STREET 1: 501 BOYLSTON STREET, SUITE 6102
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-327-7737
MAIL ADDRESS:
STREET 1: 501 BOYLSTON STREET, SUITE 6102
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: CAPSTAR SPECIAL PURPOSE ACQUISITION CORP.
DATE OF NAME CHANGE: 20200227
D
1
primary_doc.xml
X0708
D
LIVE
0001805087
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
617-456-4718
DELAWARE
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP.
Corporation
true
2020
Yishai
Zohar
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Executive Officer
Director
David
Pass
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Executive Officer
Harry
L.
Leider
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Executive Officer
Elaine
Chiquette
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Executive Officer
Alessandro
Sannino
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Executive Officer
Elliot
Maltz
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Executive Officer
David
Abraham
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Executive Officer
Paul
Fonteyne
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Director
Raju
Kucherlapati
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Director
Jane
Wildman
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Director
Dominic
Perks
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Director
Alison
Bauerlein
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Director
Clayton
Christopher
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Director
Kathryn
Cavanaugh
GELESIS HOLDINGS, INC.
501 BOYLSTON STREET, SUITE 6102
BOSTON
MA
MASSACHUSETTS
02116
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2022-08-11
true
true
false
0
50575684
575684
50000000
Total Offering Amount represents the aggregate of (i) up to $50,000,000 of common stock and (ii) 355,361 shares of common stock issued as consideration for entering into the Purchase Agreement. See the Issuer's Current Report on Form 8-K filed on 8/12/22.
false
1
0
0
0
false
GELESIS HOLDINGS, INC.
/s/ Elliot Maltz
Elliot Maltz
Chief Financial Officer and Treasurer
2022-08-24